For the latest in reexamination and post-grant news, and all issues of KeepIngTabs, click HERE.
As part of AIPLA’s 2018 Mid-Winter Institute’s Leadership Development segment, Harry will participate in a panel discussion on Developing Leadership and Leadership Skills from Private Practice, Corporate and Government Perspectives. Harry is particularly well-suited for this panel having spent 10 years in the US Patent and Trademark Office, 30 years in Corporate Practice as Chief Patent Counsel at several major corporations, and the last 7 years here at Greenblum & Bernstein.
On November 29, 2017, Harry presented a webinar entitled “IP Strategy Stories from the Front Lines.” Harry spent over 30 years as an in-house counsel, building up the IP portfolios of four major US and multinational corporations, including growing one company's patent portfolio from 30 to 1,400 patents. During this webinar Harry addressed some of the IP strategy challenges he faced in these roles, as well as sharing some success stories achieved on the way to reaching the companies' IP visions.
On September 19, 2017, Neil F. Greenblum and Justine Nespoulous published an article in the French version of LexisNexis (Juris Classeur). Greenblum, N. and Nespoulous J., Droit américain des brevets – Les procédures non judiciaires après délivrance, Encyclopédie JurisClasseur Brevets - Fasc. 4489-20 (2017).
On August 16, 2017, Harry Gwinnell was a guest speaker at the Intellectual Property Owners Women in IP monthly teleconference meeting. Harry spoke on the topics of his corporate diversity experiences especially at Cargill and Eastman Chemical Company, his perspective on support for women and minorities in the IP profession based on his experiences, and his work with the IPO Education Foundation. The meeting concluded with an extensive question and answer session with participants.
On August 16, 2017, Harry Gwinnell made a presentation on “What Should I Protect? What Should I Monetize? Strategic Innovation Decisions” at the United States Patent and Trademark Office Global Intellectual Property Academy, Association for Southeast Asian Nations. The presentation was part of the USPTO-ASEAN IP Office Administration Program – “Conception to Commercialization.” Participants were from Southeast Asia locations including Cambodia, Viet Nam, Thailand and Indonesia, among others.
G&B is proud to announce that for the second year running, our co-managing partner, Bruce Bernstein, has been honored as one of the world’s leading patent lawyers by Who’s Who Legal: Patents 2017. Bruce is one of only six attorneys in Virginia to receive that honor.
In April, Bill Boshnick of Greenblum & Bernstein, PLC in Reston, Virginia recently lectured before the Japan Patent Attorneys Association (JPAA) in Tokyo and Osaka, Japan. Bill discussed export control issues and other patent problems encountered by foreign companies having U.S. subsidiaries.
Harry Gwinnell and Michael Fink presented at the Best Practices in Intellectual Property Conference on March 27-28, 2017 in Tel Aviv, Israel. G&B was a Gold Sponsor of the event. Harry was on the featured panel “THE BIG DEBATE: Patent or WHAT ELSE?” and led a Master’s Class on the Strategic Operation of a Corporate IP Department. Michael was on a panel discussing “Methods of Attacking Patents at the Patent Offices: Comparing Procedures in Europe, US and China” and also facilitated a luncheon discussion on the value of patents in the absence of infringement.
On March 1, 2017, Paul Braier spoke at the 6th Annual Pharma IPR 2017 conference in Mumbai, a leading forum for IP professionals from leading Indian and global pharma companies and law firms. Paul spoke about FDA’s new rules and guidances, and how they affect generic drug companies. For the third year running, G&B is a Silver Sponsor for this premier event. More information on the conference can be found here (http://www.pharmaipr-india.com/). Click here for a copy of the presentation.
Branko Pejic was on the organizing committee for the FICPI ABC meeting held in Miami, March 12-15, and Mr. Pejic also spoke on an international panel discussing recent intellectual property trends and developments in the Biologics and Pharmaceutical Industries. Click the following link for additional information on the FICPI ABC Conference as well as Mr. Pejic’s panel http://www.ficpi.us/